All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.

TitleAll-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.
Publication TypeJournal Article
Year of Publication2012
AuthorsLewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, Wasmuth J, van Sighem A, Kirk O, Obel N, Panos G, Ghosn J, Dabis F, Mary-Krause M, Leport C, Pérez-Hoyos S, Sobrino-Vegas P, Stephan C, Castagna A, Antinori A, Monforte A, Torti C, Mussini C, Isern V, Calmy A, Teira R, Egger M, Grarup J and Chêne G
Corporate AuthorsCollaboration of Observational HIV Epidemiological Research Europe(COHERE) in EuroCoord
JournalInt J Epidemiol
Volume41
Issue2
Pagination433-45
Date Published2012 Apr
ISSN1464-3685
KeywordsAdult, Anti-HIV Agents, Cause of Death, CD4 Lymphocyte Count, Cohort Studies, Europe, Female, HIV Infections, Humans, Male, Poisson Distribution, Risk Factors
Abstract

BACKGROUND: Using data from a large European collaborative study, we aimed to identify the circumstances in which treated HIV-infected individuals will experience similar mortality rates to those of the general population.METHODS: Adults were eligible if they initiated combination anti-retroviral treatment (cART) between 1998 and 2008 and had one prior CD4 measurement within 6 months. Standardized mortality ratios (SMRs) and excess mortality rates compared with the general population were estimated using Poisson regression. Periods of follow-up were classified according to the current CD4 count.RESULTS: Of the 80 642 individuals, 70% were men, 16% were injecting drug users (IDUs), the median age was 37 years, median CD4 count 225/mm(3) at cART initiation and median follow-up was 3.5 years. The overall mortality rate was 1.2/100 person-years (PY) (men: 1.3, women: 0.9), 4.2 times as high as that in the general population (SMR for men: 3.8, for women: 7.4). Among 35 316 individuals with a CD4 count ≥500/mm(3), the mortality rate was 0.37/100 PY (SMR 1.5); mortality rates were similar to those of the general population in non-IDU men [SMR 0.9, 95% confidence interval (95% CI) 0.7-1.3] and, after 3 years, in women (SMR 1.1, 95% CI 0.7-1.7). Mortality rates in IDUs remained elevated, though a trend to decrease with longer durations with high CD4 count was seen. A prior AIDS diagnosis was associated with higher mortality.CONCLUSIONS: Mortality patterns in most non-IDU HIV-infected individuals with high CD4 counts on cART are similar to those in the general population. The persistent role of a prior AIDS diagnosis underlines the importance of early diagnosis of HIV infection.

DOI10.1093/ije/dyr164
Alternate JournalInt J Epidemiol
PubMed ID22493325